Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $63.3M | $49.9M | $50.8M | $59.1M |
| Gross profit | $6.3M | $6.5M | $8.6M | $9.0M |
| Gross margin | 9.95% | 13.10% | 16.97% | 15.24% |
| Research & development | $1.7M | $1.9M | $607,484 | $318,308 |
| Operating expenses | $8.8M | $5.4M | $5.9M | $5.8M |
| Operating income | −$2.5M | $1.1M | $2.7M | $3.2M |
| Operating margin | −4.03% | 2.25% | 5.35% | 5.42% |
| EBITDA | −$2.2M | $1.4M | $3.0M | $3.4M |
| EBITDA margin | −3.43% | 2.90% | 5.87% | 5.83% |
| Net income | −$2.7M | $470,987 | $1.1M | $1.6M |
| Net profit margin | −4.26% | 0.94% | 2.16% | 2.74% |
| Basic EPSper basic share | -$0.10 | $0.02 | $0.04 | $1.17 |
| Diluted EPSper diluted share | -$0.10 | $0.02 | $0.04 | $1.17 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
HRT FINANCIAL LP | 23.93K |
Tower Research Capital LLC (TRC) | 5K |
UBS Group AG | 30 |
Caitong International Asset Management Co., Ltd | 30 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.